// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Procedural and anatomic predictors of response in RADIANCE-HTN SOLO: a multicenter, randomized, sham-controlled trial of endovascular ultrasound renal denervation

Ajay Jayant Kirtane - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Gennaro Giustino - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

N/A

Effect of Baseline Anemia on Outcomes After PCI and CABG in Patients With Left Main Disease: The EXCEL Trial

Prakriti Gaba - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

N/A

Impact of Cardiovascular Rehospitalizations Following PCI vs. CABG For Left Main Coronary Artery Disease: A Sex-Specific Analysis From the EXCEL Trial

Ioanna Kosmidou - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

R. Jay Widmer - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Left main disease

Adenosine

Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary artery lesions

Everolimus

Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Ashok Seth - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coronary artery lesions

sirolimus

The effects of stent post-dilatation during primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI): Insights from optical coherence tomography (OCT) and coronary physiology

Grigoris Karamasis - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration

Stephanie Sellers - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Procedural success and outcomes with increasing use of enabling strategies for chronic total occlusion intervention: an analysis of 28,050 cases from the British Cardiovascular Intervention Society database

Tim Kinnaird - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

The Physiological Pattern of Disease Assessed by Pressure Wire Pullback has an Influence on Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance: Insight From Multicenter AJIP Registry

Takayuki Warisawa - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predicting angina-limited exercise capacity using coronary physiology

Christopher Cook - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Preserving coronary access after Valve-in-TAVI: a glimpse into the future.

Nicola Buzzatti - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence, Predictors and Outcomes of Device-Related Thrombus After Left Atrial Appendage Closure With The WATCHMAN Device. Insights From the EWOLUTION Real World Registry.

Alexander Sedaghat - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left atrial appendage occlusion

N/A

Non-periprocedural Myocardial Infarction After CABG in Patients With Left Main Disease: Analysis From the EXCEL Trial

Mahesh Madhavan - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry

Kamilia Moalem - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Patient-oriented clinical outcomes and net adverse cardiovascular event in the Global Leaders trial

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stable coronary artery disease

Clopidogrel bisulfate

The impact of bifurcation stenting techniques on the clinical events: the stratified analysis of 2,510 bifurcated lesions according to MADS classification in the Global LEADERS trial

Norihiro Kogame - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Ticagrelor

Impact of Clinical Syndrome on Outcomes After PCI: Analysis From a Large Pooled Randomized Trial Dataset

Masaru Ishida - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Copyright © 2026. QuantiNova All rights reserved